Stock BIAF BIOAFFINITY TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.53 USD +6.75% Intraday chart for bioAffinity Technologies, Inc. -15.67% +72.05%
Apr. 01 BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 20 BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
BU
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BU
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
BU
BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding
CI
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
AQ
BioAffinity Technologies Closes $2.5 Million Equity Offerings
MT
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
PR
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BU
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
PR
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BU
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung
AQ
BioAffinity Technologies, Inc. announced that it expects to receive $2.624 million in funding
CI
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
BU
BioAffinity Technologies News Update
BU
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice
AQ
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
BU
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board
CI
BioAffinity Technologies In The News
BU
BioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIAF Stock
  4. News bioAffinity Technologies, Inc.